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Human pregnancy is associated with a mild pro-inflammatory state, characterized by 
circulatory neutrophil activation. In order to explore the mechanism underlying this alter-
ation, we examined NETosis during normal gestation. Our data indicate that neutrophils 
exhibit a pro-NETotic state, modulated in a multimodal manner during pregnancy. In gen-
eral, circulatory granulocyte colony-stimulating factor, the levels of which increase during 
gestation, promotes neutrophil extracellular trap (NET) formation. Early in pregnancy, 
NETosis is enhanced by chorionic gonadotropin, whereas toward term is stimulated by 
estrogen. A complex interaction between estrogen and progesterone arises, wherein 
progesterone restrains the NETotic process. In this state, extensive histone citrullination 
is evident, yet full NETosis is inhibited. This coincides with the inability of neutrophil elas-
tase to translocate from the cytoplasm to the nucleus and is regulated by progesterone. 
Our findings provide new insight concerning gestational and hormone-driven patholo-
gies, since neutrophil recruitment, activation, and NET release could be associated with 
excessive endothelial and placental injury.
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inTrODUcTiOn
Pregnancy presents a unique challenge for the maternal immune system, which is modulated in 
such a manner that the mother accepts her semi-allogeneic fetus, yet is still capable of mounting 
an effective response against infections (1, 2). Although a considerable body of knowledge has been 
accumulated regarding the role of T lymphocytes, regulatory T cells, or natural killer cells in toler-
ance promotion or tissue modification during gestation, the role of the innate immune response 
and the involvement of neutrophils in particular has not been examined to the same extent in 
Abbreviations: citH3, citrullinated histone H3; DAPI, 4′,6-diamidino-2-phenylindole; E2, β-estradiol; E3, estriol; EIA, enzyme 
immunoassay; G-CSF, granulocyte colony-stimulating factor; hCG, human chorionic gonadotropin; MPO, myeloperoxidase; 
NADPH, nicotinamide adenine dinucleotide phosphate oxidase; NE, neutrophil elastase; NET, neutrophil extracellular trap; 
P4, progesterone; PAD4, peptidyl arginine deiminase IV; PMA, phorbol myristate acetate; RA, rheumatoid arthritis; ROS, 
reactive oxygen species; SLE, systemic lupus erythematosus.
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normal pregnancy (3). There is a need to address this, since a 
comprehensive body of evidence implicates aberrant neutrophil 
activity in severe pregnancy complications such as preeclampsia 
(PE), recurrent fetal loss, or poor pregnancy outcome due to 
autoimmune conditions such as systemic lupus erythematosus 
(SLE) (4–8). In part, these pathologies appear to entail an exces-
sive alteration of the moderately increased inflammatory activity 
of circulatory neutrophils in normal pregnancy (4, 9). Such 
overt neutrophil activity is proposed to contribute to increased 
neutrophil extracellular traps (NETs) in preeclamptic placentae 
or, as recently shown, those affected by SLE (10–12).
Neutrophils play a key role in the immediate response to 
infections, employing an array of weapons including phagocy-
tosis, release of toxic granular enzymes and of reactive oxygen 
species (ROS), or the generation of NETs to dispose of harm-
ful microorganisms (13, 14). NETs are a rather unique innate 
immunity tool, being formed by the extrusion of nuclear DNA 
into the extracellular environment, where they ensnare a wide 
array of microorganisms, ranging from bacteria and fungi to 
parasites (15). Aberrant NET formation may induce damage or 
cell death of neighboring tissues and has been implicated in a 
number of pathologies including rheumatoid arthritis (RA), SLE, 
small vessel vasculitis, or coagulopathies (16). The underlying 
signal-transducing pathway initiating NETosis involves calcium 
mobilization, generation of ROS by NAPDH oxidase, nuclear 
transfer of neutrophil elastase (NE), myeloperoxidase (MPO), 
and peptidylarginine deiminase 4 (PAD4), and histone citrullina-
tion by the latter (17–21). These events contribute to chromatin 
unfolding, a prerequisite for efficient DNA extrusion (21–23).
To date, the generation of NETs and the regulation of their 
release have not been studied during the three trimesters of normal 
human pregnancy (7, 12). Our data indicate that neutrophils from 
normal healthy pregnancies exhibit a distinctive pro-NETotic 
phenotype, which increases toward term. It was determined that 
granulocyte colony-stimulating factor (G-CSF) not only contrib-
utes to increasing neutrophil counts during gestation but also 
to progressively enhanced NETosis. Early in gestation, NETosis 
is augmented by the action of human chorionic gonadotropin 
(hCG), while toward term the steroid sex hormones estradiol 
(E2) and progesterone (P4) modulated neutrophil activity in a 
complex manner. While E2 acts to promote NET formation, P4 
acts as an antagonist, by retaining neutrophils in an advanced 
primed state, thus hindering progression of NETosis. Our find-
ings suggest that the regulatory mechanism evoked by P4 involves 
the prevention of NE transfer from the cytoplasm to the nucleus, 
a step previously demonstrated to be vital for effective NET 
formation (18).
MaTerials anD MeThODs
human subjects
Pregnant women were recruited at the time of their routine 
examination at the end of the first (median gestational age: 
12 weeks and 4 days – n = 15; median age: 34.1 years) and second 
trimesters (median gestational age: 24 weeks and 3 days – n = 25; 
median age: 34.1 years) and at the time of elective cesarean sec-
tion toward the end of the third trimester (median gestational age 
at delivery: 38 weeks and 4 days – n = 35; median age: 34.1 years) 
(Table S1 in Supplementary Material). Healthy non-pregnant 
controls, matched for age (n  =  45; median age: 33.5  years), 
were recruited at the Blood Bank of the Swiss Red Cross, Basel 
(Table S1 in Supplementary Material). Inclusion criteria for non-
pregnant controls were fair general condition, female sex, age ≥25 
and ≤45 years, and for blood donors fulfilling national criteria 
for blood donation. Exclusion criteria were current or previous 
systemic autoimmune disease, asthma, reconvalescence after 
major illness, surgery, current medication with corticosteroids, 
immunosuppressive agents and malignant neoplasia, or chemo-
therapy within 5 years before recruitment for the study. Exclusion 
criteria for pregnant subjects included any major complication of 
pregnancy or coincident disease, such as PE, pre- or post-term 
labor (<37 or >42 weeks), intrauterine growth retardation, and 
viral, bacterial, or parasitic infections. Informed, written consent 
was obtained from all subjects prior to inclusion in the study, 
which was approved by the Ethical Review Board of Basel/Basel-
Land, Switzerland.
Blood cell count and Preparation of 
Plasma and serum
Whole blood was collected into EDTA- and silicone-coated 
tubes (Sarstedt), and 25 μl of blood was analyzed by a Hemavet 
950FS (Drew Scientific) for complete blood cell counts. Plasma 
and serum was collected and processed as described previously 
(24). Samples were studied immediately or stored at −80°C until 
analyzed.
human neutrophil isolation
Neutrophils were isolated by Dextran–Ficoll density centrifuga-
tion (25). Cell viability was assessed by trypan blue dye exclusion 
via a hemocytometer and was measured routinely 96–98% with a 
purity of over 95%. Neutrophils were directly seeded in 24-well or 
96-well plates and allowed to settle for 15 min at 37°C under 5% 
CO2 prior to further experimentation. Time-points of measure-
ments are given in the figure legends.
stimulation and neutralization studies
For in vitro incubation studies, 2.5 × 104 neutrophils from healthy 
women were treated with 3% serum or 6% plasma derived from 
non-pregnant controls and pregnant donors during the first, 
second, and third trimesters of gestation. All experiments were 
carried out over 3 h in four to six replicates.
Neutrophils from healthy controls were incubated with 
ascending concentrations of hCG, E2, E3, P4, or G-CSF, which 
covered the physiological plasma concentrations during gesta-
tion, individually or in different combinations.
For the two-step stimulation in vitro experiments, neutrophils 
were pretreated with hormones or G-CSF as a primary stimulus 
for 60 min, and then exposed to the secondary stimulus (PMA or 
G-CSF) for another 120 min, for a total time of 3 h.
To neutralize sex hormones’ activity, pooled sera or plasma 
from the study groups of interest were pretreated for 30  min 
with fulvestrant (10 μg/ml, Sigma) and mifepristone (10 μg/ml, 
Sigma) and used for a 3-h treatment of control neutrophils for 
the inhibition of estrogen and progestin receptors, respectively. 
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To neutralize G-CSF, pooled sera or plasma from the study groups 
of interest were pretreated with anti-G-CSF antibody (0.2 μg/ml, 
Peprotech) for 30 min.
Fluorimetric Quantification and 
Fluorescence Microscopy
NETs were quantified by SytoxGreen fluorimetry (10, 20, 26). 
2.5 × 104 freshly isolated neutrophils were cultured in the pres-
ence of 0.2  μM SytoxGreen (Invitrogen, Life Technologies) in 
a 96-well dark microtiter plate at 37°C under 5% CO2 and left 
untreated or stimulated with the aforementioned agents over 
3 h. PMA (25nM) was used as the positive control. Fluorescence 
(excitation 485 nm, emission 535 nm) was measured in a Biotek 
Synergy H1 Hybrid Reader (Biotek) and results given as DNA 
mean fluorescence intensity (MFI). Photomicrographs in bright 
field and green fluorescence spectra were assessed with an 
Olympus IX50 inverted fluorescence microscope coupled to an 
Olympus XM10 monochromatic CCD camera and analyzed with 
the Olympus CellSens Dimension software (Olympus).
neutrophil Viability
Apoptosis was detected by Annexin V/7-aminoactinomycin D 
(7-AAD) staining (BD BioSciences) according to the manufac-
turer’s instructions. 104 cells were counted by flow cytometry 
using a BD Accuri™ C6 flow cytometer (Becton-Dickinson). The 
data were analyzed using Flowjo v10 software (Treestar).
cytokine Proteome array
Cytokines, chemokines, and acute phase proteins were detected 
with the Human Cytokine Array Kit (R&D Systems) according 
to the manufacturer’s instructions. Pooled sera collected from 
control non-pregnant individuals and pregnant donors during 
the first, second, and third trimesters of gestation were centri-
fuged and incubated with the pre-coated nitrocellulose mem-
branes. After washing and addition of the detection antibody 
streptavidin–HRP conjugates, the membranes were exposed to 
X-ray film (Fuji). The cytokine proteomic array comprised 36 
targets spotted in duplicate on the membranes. The intensity 
of each spot in the captured images was analyzed with ImageJ 
analysis software (NIH Image Processing).
ne, MPO, cell-Free histone/Dna 
complex, MPO/Dna complex, 
and g-csF Protein analysis
The concentrations of NE and MPO were measured in sera and 
plasma by sandwich ELISA, utilizing, respectively, the Elastase/
a1-PI Complex ELISA Kit (Calbiochem) and the human MPO 
ELISA Kit. Histone/DNA complexes in sera and plasma were 
measured using the Human Cell Death Detection ELISAPLUS 
(Roche Diagnostics); nucleosomes in cell culture supernatants 
were detected similarly after incubation with DNase I (10 U for 
5 min) (Roche Diagnostics). To identify NET-associated MPO/
DNA complexes, a modified capture ELISA was utilized (27). 
NET-associated MPO in culture supernatant was captured using 
the coated 96-well plate of the human MPO ELISA Kit (Hycult 
Biotech), and the NET-associated DNA backbone was detected 
using the anti-DNA-POD antibody of the Human Cell Death 
Detection ELISAPLUS (Roche Diagnostics). G-CSF serum and 
plasma protein concentrations were assessed with the Human 
G-CSF Quantikine ELISA Kit (R&D Systems).
Oxidative Burst analysis
Nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase-mediated ROS production was measured either by a 
2′,7′-dichloro dihydrofluorescein diacetate (DCFH-DA) plate 
assay (28) or a luminol-based chemiluminescence microtiter plate 
assay (29, 30). Also, 2.5 × 104 neutrophils per well were incubated 
without or with stimulants mentioned above in dark 96-well 
microtiter plates with 25 μM DCFH-DA (Sigma-Aldrich), which 
reacts with ROS species produced in intracellular compartments 
(granules or phagosomes). Fluorescence was recorded immedi-
ately in a Biotek Synergy H1 Hybrid plate Reader (Biotek) for 
30 min. The response was expressed as relative fluorescence units 
(RFU). Similarly, 2.5 × 104 neutrophils per well were incubated 
without or with the aforementioned stimulants in white 96-well 
microtiter plates with 60μM luminol (5-amino-2,3-dihydro 
1,4-phthalazinedione). Chemiluminescence was recorded every 
5 min over a period of 30 min in a Biotek Synergy H1 Hybrid 
plate Reader (Biotek), and the response was expressed as relative 
luminescence units (RLU).
immunohistochemistry, Morphometric 
analysis, and confocal Microscopy
The 1  ×  105 neutrophils were seeded on poly-l-lysine-coated 
glass coverslips (BD Biosciences) in 24-well tissue-culture plates 
and allowed to settle prior to stimulation as described above. 
Coverslips were rinsed with ice-cold HBSS and the cells fixed with 
4% paraformaldehyde and blocked overnight (HBSS with 10% 
FBS, 0.1% Tween20, and 2mM EDTA) at 4°C. NETs were detected 
with rabbit anti-NE (Abcam), rabbit anti-MPO (Dako), and 
rabbit anti-citrullinated histone H3 (citH3, Abcam). Secondary 
antibodies were goat anti-rabbit IgG AF555, goat anti-rabbit IgG 
AF488 (Invitrogen Life Technologies), and goat anti-mouse IgG 
AF647. DNA was stained with 4′,6-diamidino-2-phenylindole 
(DAPI, Sigma-Aldrich). NETs were visualized by using a Zeiss 
Axioplan 2 Imaging fluorescence microscope in conjunction 
with a Zeiss AxioCam MRm monochromatic CCD camera and 
analyzed with Axiovision 4.8.2 software (Carl Zeiss). A minimum 
of 20 fields (at least 1,000 neutrophils) per case was evaluated for 
MPO/NE and DNA co-staining; nuclear phenotypes and NETs 
were counted and expressed as percentage of the total number of 
cells in the fields.
In another setup, NETs were quantified by IHC staining 
of 2.5 × 104 neutrophils per well in a 96-well plate with mouse 
anti-human MPO antibody (Abcam) and rabbit anti-human 
citH3 antibody (Abcam), or the respective isotype controls, 
followed by incubation with goat anti-mouse IgG AF555 and 
goat anti-rabbit IgG AF488 (Invitrogen Life Technologies). DNA 
was counterstained with DAPI (Sigma-Aldrich). NETs were 
visualized by using an Olympus IX81 motorized epifluorescence 
microscope (Olympus) in conjunction with an Olympus XM10 
monochromatic CCD camera (Olympus) and analyzed with the 
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Olympus CellSens Dimension software (Olympus). A minimum 
of 20 fields at 10× magnification (at least 500–1,000 neutrophils) 
per sample were evaluated for MPO/citH3 and DNA co-staining 
through ImageJ analysis software (NIH); nuclear phenotypes and 
NETs were determined, counted, and expressed as percentage 
of the total area of cells in the fields (31). Images were captured 
on a Nikon A1R inverted microscope (Nikon) coupled to a 
Visitron CSU-W1 spinning disk confocal microscopy module 
(Visitron) and a Thor ablation laser (Thor Labs) using an UPL 
APO 60×/1.40 oil objective lens with the Visiview Cell Analyser 
software (Visitron Systems, Version 3.1.2.2).
Phagocytosis activity
Neutrophil phagocytic activity was examined by the uptake 
of latex beads coated with FITC-labeled rabbit IgG into cells 
(Cayman Chemical) according to the instruction manual. The 
1  ×  105 untreated neutrophils exposed to various stimulants 
were resuspended in 200 μl phagocytosis buffer to which FITC-
labeled beads (1:100) were added and incubated for 2 h at 37°C. 
The amount of phagocytosis was determined by flow cytometry 
utilizing the BD Accuri™ C6 flow cytometer (Becton-Dickinson) 
and analyzed by Flowjo v10 software (Treestar). The uptake of 
the beads into neutrophils was additionally captured with an 
Olympus IX50 inverted fluorescence microscope and phagocy-
tosis quantified as described above with ImageJ analysis software.
rna isolation and Quantitative  
real-time Pcr
Total RNA was isolated from 3 ×  106 neutrophils by using the 
RNeasy Mini Kit (Qiagen). TaqMan real-time quantitative 
RT-PCR was performed utilizing the Applied Biosystems 
StepOne Plus cycler (Applied Biosystems) and TaqMan Gene 
Expression Assay primer and probe sets (Applied Biosystems) 
for ELANE (HS00236952_m1), MPO (HS00924296_m1), PAD4 
(HS00202612_m1), IL-6 (HS00202612_m1), IL-8 (HS00202612_
m1), and TNF (HS00202612_m1). Data were normalized to the 
housekeeping gene B2M (HS99999907_m1), after a selection 
procedure from six different endogenous reference genes, as 
suggested in the MIQE guidelines (32). Relative values were 
calculated with 2−DDCt analysis (33).
Protein isolation and Western Blot 
analysis for PaD4 and citrullinated 
histone h3
Total protein was isolated by NucleoSpin TriPrep kit (Macherey-
Nagel) from 5  ×  106 neutrophils. All protein concentrations 
were determined with the MN Protein Quantification Assay 
(Macherey-Nagel). Western blotting was performed utilizing 
AnykD Mini-PROTEAN TGX Gels (Biorad) and nylon/nitrocel-
lulose membranes (Biorad). Primary and secondary antibodies 
utilized were rabbit anti-MPO (Cell Signalling Technologies), 
rabbit anti-PAD4 (Abcam), rabbit anti-citH3 (Abcam), mouse 
anti-β-Actin (Sigma), anti-rabbit HRP (Santa Cruz), and anti-
mouse HRP (Santa Cruz). HRP activity was detected by using 
SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific). Equal loading was verified using beta-actin. Western 
blots of citrullinated H3 (citH3) protein were prepared as 
described previously (34). Gel documentation, densitometric 
analysis, and protein quantification of the western blots was 
performed using the ChemiDoc XRS+ imaging system (Biorad) 
with the ImageLab 4.1 image analysis software (Biorad).
statistical analysis
All data are presented as mean ±  SE. Descriptive statistics for 
continuous parameters consisted of median and range, and cat-
egorical variables were expressed as percentages. Comparisons 
between patients and healthy controls were carried out by 
the Mann–Whitney U test with a Welch post-test correction. 
Statistical significance in multiple comparisons was by one-way 
analysis of variance (ANOVA) with a Dunn’s post-test correction. 
P values under <0.05 were considered statistically significant. 
Data were processed in GraphPad Prism version 6.0 for MacOSX 
(GraphPad Software Inc.1). Professional statistical assistance was 
provided by Andreas Schoetzau.2
resUlTs
Pregnancy is associated with a  
Pro-neTotic state That increases 
with advancing gestation
An initial examination of circulatory neutrophils isolated from 
normal maternal blood samples with SytoxGreen, a cell imperme-
able DNA dye, indicated that they exhibited an increased tendency 
to form NETs in vitro, when compared to matching non-pregnant 
control donors (Figure 1A; Video S1 in Supplementary Material). 
This was most evident after culturing for 3 h, as confirmed by 
immunocytochemical staining (Figure 1B). To verify that these 
filamentous structures stained by SytoxGreen were indeed NETs, 
we used immunofluorescence microscopy (Figure 1B) and detec-
tion of MPO/cell-free DNA complexes in culture supernatants 
(Figure S1A in Supplementary Material). This confirmed the 
increased tendency for neutrophils to undergo increased NETosis 
with advancing gestational age. While the numbers of neutrophils 
increased during pregnancy, the proportion undergoing NETosis 
was greater than the increment in neutrophil numbers (Figure 
S1B in Supplementary Material).
Analysis of nuclear shape indicated that a significant propor-
tion of the circulatory neutrophils in pregnant women were in 
a primed pro-NETotic state, evident by a delobulated diffused 
staining pattern (Figure 1C). This enhanced pro-NETotic activity 
was mirrored by an increase in ROS production (Figure 1D), as 
well as by MPO expression and histone H3 citrullination, likely 
driven by enhanced PAD4 expression (Figure 1E), key signaling 
events required for efficient NET generation. This pro-NETotic 
phenotype was further substantiated by monitoring the response 
to other stimuli, such as that to phorbol ester (PMA), where a 
hyperresponsive increase in NET generation was observed, par-
ticularly evident in samples collected close to term (Figure 1F; 
Figures S1C,D in Supplementary Material).
1 www.graphpad.com.
2 www.eudox.ch.
FigUre 1 | neT formation and neutrophil pro-neTotic priming are augmented during pregnancy.
(Continued)
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g-csF Promotes a Pro-neTotic status 
during Pregnancy
In order to assess which circulatory factors could contribute 
to the pro-NETotic state, we examined the effect of sera from 
pregnant women on control neutrophils, where we observed that 
such treatment augmented NET formation (Figure 2A), and that 
in a gestational age-dependent manner (Figure 2B). G-CSF was 
determined to be significantly elevated in a cytokine proteome 
array analysis (Figure S2 in Supplementary Material), a feature 
confirmed by specific enzyme immunoassay (EIA) (Figure 2C). 
This piqued our interest, as this cytokine has recently been 
implicated to predisposing neutrophils toward NETosis in a 
FigUre 1 | continued 
(a) In vitro spontaneous NET formation by neutrophils from healthy pregnant donors during the three consecutive trimesters of their pregnancies over a 3-h time 
course detected by fluorescence microscopy utilizing the dsDNA-binding fluorescent SytoxGreen dye. Scale bars: 100 μm. (B) Immunofluorescence staining of 
neutrophils from healthy pregnant donors during the three trimesters of gestation for MPO (green) and DNA counterstain with DAPI (blue) after 3 h of culture (3 h) 
compared to non-pregnant healthy donors. Scale bars: 50 μm. (c) Morphometric analysis of the NETotic and pro-NETotic primed neutrophils from healthy female 
controls and pregnant donors during the three trimesters of gestation at the baseline steady state (0 h) and over a 3-h time course (3 h). (D) Oxidative burst in 
neutrophils from healthy control donors and donors during pregnancy during the three consecutive trimesters over a 3-h time course as monitored by DCFH-DA 
detection. (e) Western blot and densitometric analysis of PAD4, citH3, MPO, and beta-actin protein expression levels in neutrophil lysates from healthy female 
controls and donors during the three trimesters of their pregnancies. (F) Fluorescent immunocytochemistry for MPO (green) and DNA counterstain with DAPI (blue) 
of neutrophils from healthy non-pregnant female controls and pregnant donors during the three trimesters of gestation after incubation for 2 h with 25nM of the 
NET-inducing agent phorbol-12-myristate-13-acetate (PMA). Scale bars: 50 μm. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and 
****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments were performed at least six times with consistent 
results. IT, first trimester; IIT, second trimester; IIIT, third trimester; P, pregnancy; RFU, relative fluorescence units; AU, arbitrary units.
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murine tumor model (35). Circulatory G-CSF appears to be an 
important contributor to the pro-NETotic state present in preg-
nancy, as a G-CSF blocking antibody diminished NET formation 
induced by plasma from pregnant women (Figures 2D,E). This 
was greatest with advanced gestation, indicating increased 
quantities of circulatory G-CSF close to term (Figure 2C). On 
the other hand, treatment of maternal plasma samples with 
the anti-G-CSF antibody led to a step-wise decrease in ROS 
production inversely proportional to advancing gestational age 
(Figure 2F). The pro-NETotic role of circulatory G-CSF during 
pregnancy was investigated by assessing the effect of different 
concentrations of recombinant human (rh)G-CSF on isolated 
normal neutrophils. rhG-CSF increased NET formation in a 
concentration-dependent manner (Figure  2G; Figure  2H, left 
panel), while 12.5 mg/ml, which corresponds to the physiologic 
range in pregnancy, triggered the highest primed pro-NETotic 
state (Figure  2H, right panel) that was highly responsive to a 
secondary stimulus by PMA (data not shown). Furthermore, 
increasing doses of rhG-CSF led to concordant increases in ROS 
production (Figure  2I), while physiological concentrations 
led to increases in key NETosis signaling components, namely 
PAD4, citH3, and MPO (Figure  2J). These data suggest that 
G-CSF plays a vital role in promoting a pro-NETotic phenotype 
in pregnancy.
The gestational hormonal Milieu 
regulates neT Formation
The immune-modulatory role of hCG, estrogen, and proges-
terone during pregnancy is well documented. hCG levels peak 
at the end of the first trimester, while those of estrogen and 
progesterone reach a maximum at term (36–38). Accordingly, 
we examined their influence, focusing on the interplay between 
estrogen and progesterone, as would occur physiologically in 
preparation for parturition. As shown in Figures  3A,B, both 
hCG and estrogen promote a pro-NETotic state, as well as 
increased ROS production (Figure 3C) and elevations in citH3 
protein (Figure 3D), important hallmarks of ensuing NETosis. 
Remarkably, progesterone had a pronounced anti-NETotic effect 
(Figures 3A,B), significantly diminishing the pro-NETotic influ-
ence of estrogen (Figures 3A,B). Though progesterone curbed 
ROS production, PAD4, and MPO protein expression induced 
by estrogen (Figure 3C; Figure S3A in Supplementary Material), 
citH3 levels remained unchanged (Figure  3D), suggesting a 
differential effect on signaling leading to NETosis. A  detailed 
appraisal of the interaction between the two hormones in modu-
lating NETosis is presented in Figure  3E, where it is evident 
that physiological concentrations of progesterone hindered the 
degree of NETosis attained by applications of estrogen alone. 
Progesterone was also effective in reducing NETosis triggered 
by the powerful stimulant PMA (Figure  3F; Figures S3B,C in 
Supplementary Material).
To further analyze the modulatory role of circulatory estro-
gen and progesterone on NETosis during pregnancy, we added 
specific inhibitors of the estrogen and progesterone receptors, 
fulvestrant and mifepristone (RU486), respectively, to pregnancy 
plasma samples and assayed NET formation (Figure 3G; Figures 
S3D,E in Supplementary Material). NETosis was reduced by 
the estrogen antagonist fulvestrant (Figure  3G; Figures S3D,E 
in Supplementary Material). This effect is presumably due to 
the unopposed action of progesterone, since gestational plasma 
FigUre 2 | g-csF leads to neutrophil pro-neTotic priming during the course of pregnancy. (a) In vitro spontaneous extracellular DNA release monitored 
over a 3-h time course by SytoxGreen dye fluorescence microscopy after treatment of control neutrophils with pooled sera from women during their pregnancy. 
Scale bars: 100 μm. (B) Fluorimetric quantification of extracellular DNA release from neutrophils treated in vitro with serum from the three trimesters of pregnancy 
using dsDNA-binding SytoxGreen dye compared to the NET-inducing phorbol ester PMA (25nM). (c) Detection of G-CSF levels in sera from donors during the 
three trimesters of pregnancy by EIA. (D) Fluorescent immunostaining for MPO (red), citH3 (green), and DNA (blue) depicting the formation of NETs after in vitro 
treatment of control neutrophils with 6% pooled plasma from women during their pregnancy and 30 min pretreatment of pregnancy plasma with 50 ng/ml 
anti-G-CSF neutralizing antibody compared to plasma from control non-pregnant individuals. Scale bars: 50 μm. (e) Quantitative morphometric analysis of the 
NETotic (MPO+/DNA+) positive and pro-NETotic primed (citH3+) neutrophils from healthy non-pregnant donors under the aforementioned experimental setup. 
(F) Intracellular ROS generation from neutrophils cocultured in vitro with 6% plasma derived from donors during the three trimesters of pregnancy and 50 ng/ml 
anti-G-CSF neutralizing antibody monitored with DCFH-DA. (g) Evaluation of rhG-CSF activity by in vitro titration experiments using fluorimetric analysis of control 
neutrophils after in vitro incubation with 2.5, 12.5, and 25 ng/ml rhG-CSF compared to untreated (UT) and treated with PMA (25nM) neutrophils. 
(h) Morphometric analysis of the NETotic (MPO+/DNA+) and pro-NETotic primed (citH3+) neutrophils from healthy control donors under rhG-CSF treatment 
in vitro at the indicated concentrations compared to untreated (UT) and PMA-treated neutrophils. (i) Oxidative burst in neutrophils from healthy control donors 
treated in vitro with rhG-CSF at the indicated concentrations monitored by DCFH-DA detection and compared to untreated (UT) and PMA-treated neutrophils. 
(J) Western blot and densitometric analysis of PAD4, citH3, MPO, and beta-actin protein expression in neutrophil lysates from healthy female controls treated 
in vitro with the physiological concentrations of rhG-CSF (12.5 ng/ml). Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and 
****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments were performed at least six times with 
consistent results. IT, first trimester; IIT, second trimester; IIIT, third trimester; RFU, relative fluorescence units.
7
Giaglis et al. Neutrophil Pro-NETotic Priming in Pregnancy
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 565
FigUre 3 | neutrophil in vitro pro-neTotic priming is regulated by pregnancy hormones. (a) Fluorescent immunocytochemistry of peripheral neutrophils 
after incubation with physiologic pregnancy concentrations of the sex hormones hCG (50 IU/ml), E2 (20 ng/ml), P4 (50 ng/ml), and the combination of 20 ng/ml E2 
and 50 ng/ml P4 for MPO (red), citH3 (green), and DNA counterstain with DAPI (blue) after a 2-h in vitro culture. (B) Morphometric analysis of the NETotic (MPO+/
DAPI+) neutrophils from healthy control donors under the aforementioned hormonal in vitro treatment. (c) Oxidative burst in neutrophils from healthy control 
donors treated with physiologic pregnancy concentrations of hCG, E2, P4, and the combination of E2 and P4 for 3 h by DCFH-DA. (D) Western blot analysis of 
PAD4, citH3, MPO, and beta-actin protein expression levels in lysates from healthy female control neutrophils treated in vitro with the aforementioned 
concentrations of sex hormones. (e) Information graphic summarizing the in vitro spontaneous NET release monitored by dsDNA-binding fluorescent SytoxGreen 
dye in a 3-h time course after treatment with four ascending concentrations of each of the gestational hormones hCG, E2, E3, and P4, separately or in crosswise 
combinations. (F) Morphometric analysis of the NETotic (MPO+/DAPI+) and pro-NETotic primed (citH3+) neutrophils from healthy non-pregnant donors after 1 h 
pretreatment with physiologic concentrations of hCG, E2, P4, and E2/P4 and stimulation with 25nM of the NET-inducing agent PMA as a second hit for additional 
2 h in vitro. (g) Detection of in vitro spontaneous NET formation of neutrophils from healthy controls cocultured with pregnancy plasma pretreated with 10 μg/ml of 
the specific inhibitors of the estrogen and progesterone receptors, fulvestrant and mifepristone (RU486), respectively, over a 3-h time course by fluorescence 
microscopy using morphometric analysis of the NETotic (MPO+/DAPI+) and pro-NETotic primed (citH3+) neutrophils. Data are presented as mean ± SEM. 
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments were 
performed at least six times with consistent results. RFU, relative fluorescence units; Pla, pregnancy plasma.
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samples contain an assortment of sex hormones. On the other 
hand, in samples treated with mifepristone, thereby inhibit-
ing progesterone, NETosis was significantly increased. In this 
instance, the effect would be attributable to unopposed estrogen 
in the plasma sample.
These results show that NET formation is tightly regulated by 
the gestational hormonal milieu.
Progesterone confines neTosis of 
neutrophils at an advanced state of Priming
During our experiments utilizing the blocking anti-G-CSF anti-
body in maternal plasma, we noted that such treatment not only 
led to a substantial reduction in NET formation (Figure 2E) but 
also to a significant increase in the number of primed citH3+ 
cells (Figure  4A). Since the anti-NETotic effect of G-CSF was 
FigUre 4 | sex hormones differentially modulate g-csF-driven neutrophil pro-neTotic priming. (a) Morphometric analysis of the pro-NETotic primed 
(citH3+) neutrophils from healthy non-pregnant donors after in vitro incubation of control neutrophils with pooled pregnancy plasma with and without in vitro 
pretreatment with anti-G-CSF neutralizing antibody compared to the priming activity of control plasma. (B) Morphometric analysis of the pro-NETotic primed 
(citH3+) neutrophils from healthy non-pregnant donors after in vitro incubation of control neutrophils with physiologic pregnancy concentrations of hCG (50 IU/ml), 
E2 (20 ng/ml), P4 (50 ng/ml), and the combination of E2 and P4 for 3 h. (c) Morphometric analysis of the pro-NETotic primed citH3+ neutrophils from healthy 
non-pregnant donors under in vitro hormonal treatment and after in vitro preincubation of control neutrophils with the sex hormone inhibitors mifepristone and 
fulvestrant. (D) Morphometric analysis of the NETotic (MPO+/DAPI+) and pro-NETotic primed (citH3+) neutrophils from healthy non-pregnant donors without and 
with pretreatment with 12.5 ng/ml rhG-CSF for 1 h (lower panel) and stimulation with the gestational hormones hCG, E2, P4, and the combination of E2 and P4 
for additional 2 h in vitro. (e) Fluorescent immunostaining and confocal microscopy for NE (red), citH3 (green), and DNA (blue) after a 3 h in vitro coculture of 
control neutrophils with rhG-CSF and addition of P4 compared to untreated control neutrophils. Scale bars: 10 μm. Data are presented as mean ± SEM. 
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments were 
performed at least three times with consistent results.
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greatest in samples collected close to term (Figure  2F), we 
speculated that this could be modulated by the pronounced anti-
NETotic activity of progesterone (Figures 3A,B), concentrations 
of which are at their peak late in pregnancy (37). We indeed 
determined that the anti-NETotic effect of progesterone was 
associated with an increase in primed neutrophils, as identified 
by citH3 staining in the nucleus (Figure 4B). When neutrophils 
were exposed to gestational plasma samples treated with the 
estrogen antagonist fulvestrant (Figure  3G; Figures S3D,E in 
Supplementary Material), this was also evident.
Under physiological conditions, the combined action of 
G-CSF and estrogen appeared to limit the anti-NETotic effect 
of progesterone (Figure  4D; Figures S4A–C in Supplementary 
Material), while in the absence of estrogen, progesterone effectively 
limited NET formation initiated by G-CSF (Figure  4E). Once 
again, this anti-NETotic effect was coupled with a pronounced 
FigUre 5 | sex hormones and g-csF regulate broader aspects of neutrophil effector functions. (a) MPO, PAD4, NE, IL-6, IL-8, and TNFα gene 
expression analysis by Taqman qRT-PCR in RNA samples obtained from healthy female controls treated in vitro with 12.5 ng/ml rhG-CSF. (B) Phagocytic activity 
of neutrophils obtained from healthy female controls treated with 12.5 ng/ml rhG-CSF. (c) PAD4, NE, MPO, IL-6, IL-8, and TNF gene expression analysis by 
Taqman qRT-PCR in RNA samples obtained from healthy female control neutrophils treated in vitro with physiologic pregnancy concentrations of hCG (50 IU/ml), 
E2 (20 ng/ml), P4 (50 ng/ml), and the combination of E2 and P4 for 3 h. (D) Phagocytic activity in neutrophils from healthy control donors treated in vitro with 
physiologic pregnancy concentrations of hCG, E2, P4, and the combination of E2 and P4 for 3 h. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, 
***P < 0.001, and ****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments were performed at least six 
times with consistent results. MFI, mean fluorescence intensity; UT, untreated.
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elevation in the number of primed neutrophils, as detected 
by citH3 staining (Figures  4C,D; Figure S4 in Supplementary 
Material).
Although the anti-NETotic action of progesterone appeared to 
involve reduced ROS production (Figure 3C), this mechanism in 
itself could not explain the high proportion of primed neutrophils 
characterized by citH3 staining (Figure  3A) or protein levels 
(Figure  3D). Rather, these data indicated that progesterone-
treated neutrophils had undergone activation, involving nuclear 
translocation of PAD4 and histone citrullination, and yet were 
unable to proceed with NETosis.
Previous studies have indicated that cleavage of linker histones 
by NE present in the nucleus is required for the unfolding of chro-
matin and subsequent NETosis (18). Upon examining this facet 
by confocal microscopy, we noted diffuse nuclear staining for NE 
in cells treated with G-CSF (Figure 4E). This was in stark contrast 
to progesterone-treated cells, where nuclear translocation of NE 
did not occur (Figure 4E). Though these cells were citH3+, they 
also retained a distinctly lobulated nuclear structure, unlike the 
G-CSF treated cells, in which the chromatin had decondensed 
and dispersed into the cytoplasm.
Further aspects of neutrophil activity 
Modulated by sex hormones and g-csF
In agreement with previous reports, we observed that preg-
nancy was associated not only with the upregulation of NET 
related molecules, such as PAD4, MPO, and NE (Figure S5A in 
Supplementary Material), but also with an increased predisposi-
tion to phagocytosis (Figure S5B in Supplementary Material) 
and degranulation (Figure S5D in Supplementary Material). In 
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parallel with the results for NETosis, both became more pro-
nounced with advancing gestation. Accordingly, we studied the 
influence of G-CSF, estrogen, and progesterone on these aspects 
of neutrophil activity. Apart from promoting NETosis, G-CSF 
enhanced the expression of the granular proteins MPO and NE 
(Figure 5A) and promoted phagocytosis (Figure 5B). G-CSF also 
enhanced the expression of pro-inflammatory cytokines such as 
IL-6, IL-8, and TNF-α by neutrophils (Figure 5A).
The effect of estrogen and progesterone was more differenti-
ated, with the former significantly enhancing the expression of 
MPO and NE, as well as that of IL-6 and TNF-α, in contrast to 
the rather dampened effect mediated by the latter (Figure 5C). 
Interestingly, both estrogen and progesterone trigger enhanced 
IL-8 expression, an important chemokine for neutrophil recruit-
ment, degranulation, and NETosis (10, 39). This finding is impor-
tant, since neutrophil expression of IL-8 progressively increases 
with advancing gestational age (Figure S5C in Supplementary 
Material), thereby indicating an important role of this pivotal 
cytokine in regulating neutrophil activity in pregnancy. In general, 
the influence of hCG was similar to that of estrogen, albeit to a 
lower level (Figures 5C,D). Furthermore, phagocytic activity was 
significantly more enhanced by progesterone treatment than by 
estrogen alone or by the combination of both (Figure 5D). These 
findings suggest that by blocking NETosis, progesterone may shift 
neutrophil antimicrobial activity toward other pathways, such as 
phagocytosis.
DiscUssiOn
A crucial contribution to our understanding of PE, a highly 
inflammatory condition during gestation, was the seminal 
observation that it involved an excessive maternal inflammatory 
response to pregnancy (4). This was based on the finding that 
human pregnancy is associated with a subliminal inflammatory 
condition, characterized by enhanced neutrophil activation, 
which is most extreme in PE (3, 40, 41). The possible involvement 
of overtly activated neutrophils in the etiology of PE was further 
supported by the detection of large numbers of NETs in the 
intervillous space of affected placentae (10). Furthermore, data 
from animal models suggested that tissue-resident proangiogenic 
decidual neutrophils (42) and activation of circulatory neutro-
phils via the complement cascade may contribute to PE-like 
conditions or those associated with fetal loss (43, 44). The latter 
is supported by recent reports that antiphospholipid antibodies, 
which are frequently detected in cases with recurrent fetal loss, 
trigger NETosis [reviewed in Ref. (7)].
Unfortunately, the prominent focus on the role of neutrophils 
in pathological conditions has yielded few advances in the knowl-
edge of their behavior during normal pregnancy (7, 12). As an 
understanding of the NETotic response in normal pregnancy 
could provide better insight into pathological subversion, it was 
the focus of our current study. Our data indicate that (i) circula-
tory neutrophils from pregnant women exhibit an enhanced 
pro-NETotic response, which increases with advancing gesta-
tion; (ii) pro-NETotic priming is mediated largely by G-CSF; (iii) 
NETosis is modulated in an opposing fashion by estrogen and 
progesterone; and (iv) in that progesterone locks neutrophils in 
a highly pro-NETotic state by hindering NE migration to the 
nucleus. Since neutrophil NETs were originally described as an 
antimicrobial mechanism (39), our data suggest that this opera-
tive arm of the innate immune response is highly proactive in 
human pregnancy. In this manner, by being in a highly primed 
pro-NETotic state, such pre-activated neutrophils could react 
immediately to a threat by pathogens.
Early in gestation, enhanced NETosis seems to be largely driven 
by hCG, which plays a pivotal role during this phase of pregnancy, 
with a minimal contribution by G-CSF. Interestingly, in  vitro 
application of hCG leads to a significant increase in PAD4 expres-
sion, without a major increment in citH3 levels. Furthermore, 
ROS production, a further key element in the NETotic cascade, 
was not significantly elevated by hCG treatment, underlining a 
possible ROS-independent mechanism driving the generation of 
NETs as described recently (45). As gestation advances, it becomes 
apparent that a discrete interaction between G-CSF and steroid sex 
hormones modulates pro-NETotic activity. In this regard, elevated 
concentrations of G-CSF during pregnancy not only serve to 
increase the pool of circulatory neutrophils but also to promote 
a primed pro-NETotic phenotype. This is achieved by triggering 
increased PAD4 expression and concomitant histone H3 citrul-
lination, essential steps in the NETotic signaling cascade (21, 22).
The most intriguing aspect of our analysis was the antagonis-
tic interplay between estrogen and progesterone in regulating 
NETosis. While a host of literature supports the contrary influence 
of progesterone on estrogen-mediated effects (46), our observa-
tion is novel in that progesterone appears to exploit key signaling 
events to prevent the extrusion of NETs. Previous studies have 
shown that the triggering of NET formation requires several key 
steps, including ROS production, calcium mobilization, and acti-
vation of PKC and MAP kinases. On the other hand, untangling 
of chromatin, an a priori requirement for decondensation of the 
nuclear chromosomal DNA and its subsequent expulsion into the 
extracellular milieu, has been shown to involve citrullination of 
histones by PAD4 (21, 22), as well as the proteolytic clipping of 
histones (notably H4) by NE (18). Upon activation of neutrophils, 
ROS production leads to the release of NE from azurophilic gran-
ules into the cytosol. It then translocates to the nucleus, where 
it cleaves histones to extensively decondense chromatin (18). 
MPO, also originating from the azurophilic granules, consumes 
H2O2 to generate HOCl and other oxidants and is required for 
translocation of NE to the nucleus during NETosis by regulating 
actin dynamics (18, 23). Additionally, phagocytosis seems to 
negatively regulate NETosis (23). Our data indicate that proges-
terone downregulates ROS production in neutrophils, which is 
in concordance to previous studies showing that progesterone is 
effective in reducing ROS and NO generation driven by estradiol 
(47, 48). The observed inhibition of ROS production occurs most 
probably in favor of a significant shift towards the involvement of 
calcium signaling and PAD4 mobilization, which most probably 
promotes phagocytosis rather than degranulation or formation 
of NETs (20). The latter might lead to the excessive histone 
citrullination detected both in vitro and ex vivo, needed for the 
formation of NETs under certain stimuli, bringing NE and MPO 
into the nucleus. This translocation signifies the crucial event 
leading to the extrusion of NETs from the activated neutrophils. 
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In pregnancy, the antagonistic effect of progesterone is manifested 
by hindering translocation of NE to nucleus, thereby preventing 
terminal nuclear decondensation and disruption of the nuclear 
membrane, with subsequent intermingling between nuclear and 
cytoplasmic contents. Progesterone seems to permit histone 
citrullination by PAD4, thus effectively locking neutrophils in 
a highly primed pro-NETotic state, till triggered by a second 
stimulus that overcomes this transitory impediment.
Our data also extend upon previous reports indicating that 
circulatory neutrophils exhibit an increased propensity for 
degranulation and phagocytosis during pregnancy (4, 9), shed-
ding new light on their regulation by the action of G-CSF and sex 
hormones. In this regard, phagocytosis is enhanced by treatment 
with G-CSF. However, this is most pronounced in short-term 
cultures of 30 min, as it is drastically diminished after 2 h. In the 
instance of the hormones, the enhancement of phagocytosis is 
slower than that for G-CSF, requiring an incubation period of 
2 h for maximal effect. Of interest is that phagocytosis was most 
markedly affected by progesterone, while it is reduced when using 
estrogen in combination with progesterone under physiological 
concentrations. This suggests that progesterone may promote 
antibacterial activity involving phagocytosis rather than NETosis, 
while in combination with estrogen, this effect is diminished. It is 
also clear that the interaction between G-CSF and sex hormones 
influences a broader scope of neutrophil activity, including 
expression of key components of the NETotic cascade, such as 
PAD4, NE, and MPO, as well as pro-inflammatory cytokines 
and chemokines, such as TNF-α and IL-8. The interplay between 
these diverse facets may be important in ensuring that neutro-
phils contribute to an effective innate immune response during 
pregnancy.
In the same token, it is feasible that aberrances in this system 
may contribute to the pathogenesis of severe pregnancy-related 
conditions such as PE. This hypothesis is supported by observa-
tions that PE is associated with elevated levels of hCG (49), G-CSF 
(50), as well as indications of reduced progesterone levels (51), 
while therapy with synthetic P4 ameliorates PE symptoms in an 
animal model (52). It is therefore possible that such an imbalance 
may trigger an enhanced pro-NETotic response, which is exac-
erbated by the presence of inflammatory placental micro-debris 
(4), abundant in this condition. On the other hand, our data 
may provide a novel insight into autoimmune conditions such 
as SLE, which is associated with reduced levels of progesterone, 
both during the menstrual cycle, as well as during pregnancy (53). 
Since NETosis is altered in cases with SLE (54), it is possible that 
the negative feedback loop hindering NET formation provided by 
progesterone contributes to this phenomenon. As estrogen levels 
are normal in these patients, the altered ratio between the two 
sex steroid hormones could lead to a more facile triggering of 
the NETotic cascade. It is, hence, possible that this phenomenon 
FigUre 6 | Progesterone antagonizes the estrogen and g-csF-driven neutrophil extracellular trap formation during pregnancy. Neutrophils during 
pregnancy lie under the increased influence of cytokines, e.g., G-CSF, and sex hormones. This specific milieu appears to poise the neutrophils in a pro-NETotic 
primed state. Depending on the stimulus, neutrophils react by phagocytosis or degranulation. When a different NETotic stimulus is present, such as systemic 
infection or excessive placentally derived plasma microparticles (MP) in preeclampsia (10), primed neutrophils react with overt NET release. Pro-NETotic 
combinations of hormones and cytokines are given in green, inhibitory combinations are given in red.
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